Last reviewed · How we verify

NCT03881124

Pain Trajectories in Severe Persistent Inguinal Post-herniorrhaphy Pain

Completed Last updated 22 February 2024
What this trial tests

trial in Chronic Pain in 95 participants. Completed in 10 November 2016.

Timeline
21 August 2014
Primary endpoint
10 November 2016
10 November 2016

Quick facts

Lead sponsorUniversity of Copenhagen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment95
Start date21 August 2014
Primary completion10 November 2016
Estimated completion10 November 2016

Conditions studied

Sponsor

University of Copenhagen

Who can join

Adults 18 to 80, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Severe persistent postsurgical pain (PPP) remains a major healthcare challenge. In the third most common surgical procedure in the UK, inguinal herniorrhaphy, including 85,000 surgeries in 2015, an estimated 1,500 to 3,000 patients will annually develop severe PPP. While the trajectory of PPP is generally considered a continuation of the acute post-surgery pain, recent data suggest the condition may develop with a delayed onset. The present study evaluated pain-trajectories in a consecutive cohort referred to a tertiary PPP-center. Explanatory variables based on individual psychometric, sensory and surgical profiles were analysed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other University of Copenhagen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03881124.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing